NCT07694479 Feasibility of a Habit-Based Intervention to Reduce Sedentary Behaviour in Cancer Survivors
| NCT ID | NCT07694479 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Toronto |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-12-30 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-12-30 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cancer and its treatments are associated with long-term side effects including lowered physical strength and quality of life. Decreasing sedentary behaviour improves health outcomes in cancer survivors. Habit-based programs aimed at lowering sedentary behaviour have been successful in decreasing sedentary behaviour in other populations. However, limited clinical trials aimed at lowering sedentary behaviour have recruited cancer survivors, and none are exclusively based on Habit Theory. The primary goal of this clinical trial is to test the feasibility of an 8-week, habit-based program to lower sedentary behaviour in cancer survivors. Sedentary behaviour refers to low-energy activities performed during waking hours in a seated, reclined or laid down position. Secondarily, this clinical trial aims to examine changes in sedentary behaviour, physical strength, habit, and quality of life. Enrolled participants will be assigned to a sedentary behaviour or active control group. The sedentary behaviour group will receive 8 weekly sheets consisting of tips recommending to lower sedentary behaviour. Tips will be individualized to participants' lifestyles, and will consider their cancer-specific and other physical limitations. Participants in the sedentary behaviour group will also meet with the researcher once a week for a check-in session for more individualized tips and progressions. The active control group will receive the Canadian 24-hour Movement Guidelines, and a handout highlighting the benefits of lowering sedentary behaviour. Both groups will be provided with wearable activity monitors (Fitbits).
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * have been diagnosed with localized or asymptomatic metastatic cancer of any type * completed primary cancer treatment * self-report being sedentary for more than or equal to 8 hours per day * access to the internet and a device with a webcam * able to complete the study in English Exclusion Criteria: * presence of other primary or recurrent invasive cancer * having experienced a fall in the last 12 months * not residing in Canada * participating in other behaviour change interventions * using a gait aid device
Frequently Asked Questions
Who can join the NCT07694479 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07694479 currently recruiting?
Yes, NCT07694479 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Toronto to inquire about joining.
Where is the NCT07694479 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT07694479 clinical trial?
NCT07694479 is sponsored by University of Toronto. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.